3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes
NCT ID: NCT04601103
Last Updated: 2024-10-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
53 participants
INTERVENTIONAL
2020-01-06
2020-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial to Test the Effect of an Experimental Mouth Rinse on Gum Disease
NCT01821261
A Four-Week Study to Measure the Effectiveness of an Experimental Mouthwash Used After Teeth Cleaning
NCT01462110
A Twelve Week Study of Experimental Mouth Rinses
NCT05120141
A Clinical Study to Evaluate Effects of an Oral Rinse on Plaque and Gingivitis
NCT03421145
Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque
NCT04921371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Determine the subjects' acceptance of sloughing and/or other side effects
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Comparator: No SLS Toothpaste
3M Oral Rinse in combination with no SLS toothpaste (A)
No SLS toothpaste
Toothpaste no Sodium Lauryl Sulfate
Anti-plaque
Rinse prevents bacterial adherence to teeth
Comparator: Medium SLS Toothpaste
3M Oral Rinse in combination with medium SLS toothpaste (B)
Medium SLS toothpaste
Less than or equal to X ppm Sodium Lauryl Sulfate
Anti-plaque
Rinse prevents bacterial adherence to teeth
Comparator: High SLS Toothpaste
3M Oral Rinse in combination with high SLS toothpaste (C)
High SLS toothpaste
More than or equal to X ppm Sodium Lauryl Sulfate
Anti-plaque
Rinse prevents bacterial adherence to teeth
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No SLS toothpaste
Toothpaste no Sodium Lauryl Sulfate
Medium SLS toothpaste
Less than or equal to X ppm Sodium Lauryl Sulfate
High SLS toothpaste
More than or equal to X ppm Sodium Lauryl Sulfate
Anti-plaque
Rinse prevents bacterial adherence to teeth
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Willing to agree to maintain confidentiality of the study and study materials;
3. 3M employee aged 18 years and older;
4. Willing to return to the study facility for scheduled study visits and recalls;
5. Agree not to use other oral hygiene products (non-study toothpaste, non-study toothbrush, mouth rinse, chewing gum);
6. Agree to the study instruction and schedule
Exclusion Criteria
8. Have a dental appointment scheduled during study duration for professional cleaning;
9. Is pregnant, nursing, or planning to become pregnant within the study duration;
10. History of antibiotic therapy within the previous 30 days or have a condition that is likely to need antibiotic treatment over the course of the study (e.g., cardiac conditions requiring antibiotic prophylaxis such as heart murmurs, pacemakers, or prosthetic heart valves and prosthetic implants);
11. History of using a prescription antimicrobial mouth rinse during the past 3 months;
12. Currently taking medications which may alter gingival appearance/bleeding;
13. Currently using anticonvulsants, calcium channel blockers, or other medications with side effects known to impact oral health;
14. Participation in any other clinical study within the last 30 days;
15. Resides in the same household with a subject already enrolled in the study;
16. Known history of sensitivity to oral hygiene products;
17. Currently using tobacco products (cigarettes, chewing tobacco) or vaping products (ecigarettes);
18. History of diabetes;
19. Have removable partial/full dentures;
20. Have orthodontic appliances;
21. Have medical or oral conditions that may compromise the subject's safety or interfere with the conduct and outcome of the study;
22. Have known sloughing within the last 3 weeks;
23. Have dry mouth;
24. Have widespread caries or chronic neglect;
25. Have gross pathological changes of oral soft tissues;
26. Have advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive alveolar bone loss);
27. Unsuitable for enrollment in this study based on the professional opinion of the dental examiner based on the oral exam or other reasons not specified in the protocol
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
3M
INDUSTRY
Solventum US LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brenda C Coalwell, BA
Role: PRINCIPAL_INVESTIGATOR
3M Health Care Business Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
3M Health Care
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EM-11-050043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.